Beata Mlodawska-Morak

Jagiellońska 4 Str
Sosnowiec, OP 41200, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Novel Triazole-Diquinothiazine Hybrids Modulating Apoptosis and Stress Pathways in Colorectal Cancer Cells.

Novel Triazole-Diquinothiazine Hybrids Modulating Apoptosis and Stress Pathways in Colorectal Cancer Cells.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 19, 2026

Quinobenzothiazine-AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents.

Quinobenzothiazine-AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents.

Journal: International journal of molecular sciences
Published: May 29, 2026

Human Serum Albumin Nanoparticles as 3,6-Diazaphenothiazine Delivery System: Preparation and Interaction Studies.

Human Serum Albumin Nanoparticles as 3,6-Diazaphenothiazine Delivery System: Preparation and Interaction Studies.

Journal: Molecules (Basel, Switzerland)
Published: May 19, 2026

Cytotoxic and Antimelanoma Activity of Selected 3-Methyl-1,6-diazaphenothiazines in Human Melanoma Cells-In Vitro Studies.

Cytotoxic and Antimelanoma Activity of Selected 3-Methyl-1,6-diazaphenothiazines in Human Melanoma Cells-In Vitro Studies.

Journal: Current issues in molecular biology
Published: March 22, 2026

Molecularly Targeted Therapies in Oncology: Mechanisms, Resistance, and Combination Strategies.

Molecularly Targeted Therapies in Oncology: Mechanisms, Resistance, and Combination Strategies.

Journal: Molecules (Basel, Switzerland)
Published: March 02, 2026

Novel 8-trifluoromethylquinobenzothiazines-Synthesis and Evaluation for Antiproliferative and Antibacterial Activity.

Novel 8-trifluoromethylquinobenzothiazines-Synthesis and Evaluation for Antiproliferative and Antibacterial Activity.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 11, 2026

New 1,2,3-Triazole and Dipyridothiazine Hybrids-Synthesis, Analysis, Cytotoxicity and Molecular Docking.

New 1,2,3-Triazole and Dipyridothiazine Hybrids-Synthesis, Analysis, Cytotoxicity and Molecular Docking.

Journal: Biomolecules
Published: January 26, 2026

Design, Synthesis, Analysis, and Cytotoxicity of Novel Heteroaryl Derivatives of Dipyridothiazines.

Design, Synthesis, Analysis, and Cytotoxicity of Novel Heteroaryl Derivatives of Dipyridothiazines.

Journal: Current issues in molecular biology
Published: January 07, 2026

Study of the Lipophilicity of Tetracyclic Anticancer Azaphenothiazines.

Study of the Lipophilicity of Tetracyclic Anticancer Azaphenothiazines.

Journal: Biomolecules
Published: June 20, 2025

Design, Synthesis, and Testing of 1,2,3-Triazolo-Quinobenzothiazine Hybrids for Cytotoxic and Immunomodulatory Activity.

Design, Synthesis, and Testing of 1,2,3-Triazolo-Quinobenzothiazine Hybrids for Cytotoxic and Immunomodulatory Activity.

Journal: International journal of molecular sciences
Published: June 20, 2025

Novel 3-Methyl-1,6-Diazaphenothiazine as an Anticancer Agent-Synthesis, Structure, and In Vitro Anticancer Evaluation.

Novel 3-Methyl-1,6-Diazaphenothiazine as an Anticancer Agent-Synthesis, Structure, and In Vitro Anticancer Evaluation.

Journal: Molecules (Basel, Switzerland)
Published: May 30, 2025

A Study of Antioxidant, Antihyperlipidemic, and Anti-Glycation Effects of Alkylsulfonic Acids with Quinobenzothiazinyl Substituents: In Vitro and In Silico Investigations.

A Study of Antioxidant, Antihyperlipidemic, and Anti-Glycation Effects of Alkylsulfonic Acids with Quinobenzothiazinyl Substituents: In Vitro and In Silico Investigations.

Journal: Antioxidants (Basel, Switzerland)
Published: March 10, 2025
Showing 1-12 of 55

Last Updated: 09/26/2026